OPRX: OptimizeRx Corporation Stock

by  •  • Comments Off on OPRX: OptimizeRx Corporation Stock

SIC 7389 – Business Services, Not Elsewhere Classified

Valuation
Market Cap ($M) 100.40
Enterprise Value ($M) 121.04
Book Value ($M) 121.02
Book Value / Share 6.60
Price / Book 0.83
NCAV ($M) -5.89
NCAV / Share -0.32
Price / NCAV -17.04

Profitability (mra)
Return on Invested Capital (ROIC) -0.11
Return on Assets (ROA) -0.15
Return on Equity (ROE) -0.15

Liquidity (mrq)
Quick Ratio 3.07
Current Ratio 3.07

Balance Sheet (mrq) ($M)
Current Assets 45.97
Assets 172.88
Liabilities 51.86
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
06-10 13G/A First Light Asset Management, LLC 10.01 5.82
02-13 13G/A Vanguard Group Inc 5.62 -8.13
01-29 13G/A BlackRock Inc. 6.30 8.95
12-29 13G Divisadero Street Capital Management, LP 5.20
11-28 13G Weintraub Michael 7.60

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-08-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2024 ☐ Transition Report pursuant to 13
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2024 ☐ Transition Report pursuant to 13
2024-04-15 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2023 ☐ Transition Report pursuant t

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-10-31 18,865 95,802 19.69
2024-10-30 12,110 85,841 14.11
2024-10-29 14,601 81,889 17.83
2024-10-28 23,343 91,823 25.42

(click for more detail)

Similar Companies
NUTX – Nutex Health Inc. OCG – Oriental Culture Holding LTD
OLB – The OLB Group, Inc. PALT – Paltalk, Inc.
PAYS – Paysign, Inc.


Financial data and stock pages provided by
Fintel.io